Contracts › 75N91022C00010
75N91022C00010: Preclinical Toxicology of Large Molecule Drugs Developed for Cancer and Other Indications
Awarded to Iit Research Institute by National Institutes of Health (NIH).
$3.5Mobligated
$9.4Mpotential value
31 March 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91022C00010 |
|---|---|
| Awardee | Iit Research Institute |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NIH NCI |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | IL |
| Offers received | 4 |
| Period of performance | 01 April 2022 to 31 March 2027 |
| Potential end | 31 March 2029 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record